IN2012DN00346A - - Google Patents

Info

Publication number
IN2012DN00346A
IN2012DN00346A IN346DEN2012A IN2012DN00346A IN 2012DN00346 A IN2012DN00346 A IN 2012DN00346A IN 346DEN2012 A IN346DEN2012 A IN 346DEN2012A IN 2012DN00346 A IN2012DN00346 A IN 2012DN00346A
Authority
IN
India
Prior art keywords
formula
useful
compound
preparation
intermediates
Prior art date
Application number
Inventor
John Traverse
William W Leong
Steven P Miller
Jennifer Albaneze-Walker
Thomas J Hunter
Lijun Wang
Hongbiao Liao
Ashok Arasappan
Scott T Trzaska
Randi M Smith
Azzeddine Lekhal
Stephane L Bogen
Jianshe Kong
Frank Bennett
J George Njoroge
Marc Poirier
Shen-Chun Kuo
Yonggang Chen
Kenneth S Matthews
Patrice Demonchaux
Amadeo Ferreira
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IN2012DN00346A publication Critical patent/IN2012DN00346A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02—Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/353—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by isomerisation; by change of size of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/04—Preparation of carboxylic acid esters by reacting carboxylic acids or symmetrical anhydrides onto unsaturated carbon-to-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Processes useful for the preparation of a Compound of Formula I: Formula (I). Intermediates useful for the preparation of the compound of Formula I, and processes useful for preparing said intermediates are disclosed.
IN346DEN2012 2009-07-29 2010-07-27 IN2012DN00346A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US22961309P 2009-07-29 2009-07-29
US22964809P 2009-07-29 2009-07-29
US22965209P 2009-07-29 2009-07-29
US22961809P 2009-07-29 2009-07-29
US22963609P 2009-07-29 2009-07-29
PCT/US2010/043356 WO2011014494A1 (en) 2009-07-29 2010-07-27 ENANTIO- AND STEREO-SPECIFIC SYNTHESES OF β-AMINO-α- HYDROXY AMIDES

Publications (1)

Publication Number Publication Date
IN2012DN00346A true IN2012DN00346A (en) 2015-05-08

Family

ID=42753493

Family Applications (1)

Application Number Title Priority Date Filing Date
IN346DEN2012 IN2012DN00346A (en) 2009-07-29 2010-07-27

Country Status (12)

Country Link
US (1) US8680294B2 (en)
EP (1) EP2459525B1 (en)
JP (1) JP2013500971A (en)
CN (1) CN102639492A (en)
AR (1) AR077506A1 (en)
AU (1) AU2010276490B2 (en)
CA (1) CA2768838A1 (en)
EA (1) EA022038B1 (en)
GE (1) GEP20207101B (en)
IN (1) IN2012DN00346A (en)
SG (1) SG178115A1 (en)
WO (1) WO2011014494A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR110922A1 (en) 2017-02-06 2019-05-15 Gilead Sciences Inc HIV INHIBITING COMPOUNDS
CN115160205B (en) * 2022-07-08 2024-06-07 上海皓鸿生物医药科技有限公司 Method for preparing (S) -1- (tert-butoxycarbonyl) -2, 5-dihydro-1H-pyrrole-2-carboxylic acid and salt thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05013752A (en) 2003-06-17 2006-03-08 Schering Corp Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof.
MY145081A (en) * 2004-02-27 2011-12-15 Schering Corp Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease
WO2005097301A1 (en) * 2004-04-07 2005-10-20 K.I Chemical Industry Co., Ltd. Method of removing sulfides including hydrogen sulfide and mercaptan
EP2039689A4 (en) * 2006-05-26 2011-12-28 Kaneka Corp Process for production of optically active 3-amino-2 -hydroxypropionic cyclopropylamide derivatives and salts thereof
DE102006059317A1 (en) * 2006-07-04 2008-01-10 Evonik Degussa Gmbh Process for the preparation of β-amino-α-hydroxy-carboxylic acid amides

Also Published As

Publication number Publication date
GEP20207101B (en) 2020-05-11
EA201270223A1 (en) 2012-07-30
WO2011014494A1 (en) 2011-02-03
EP2459525A1 (en) 2012-06-06
JP2013500971A (en) 2013-01-10
AR077506A1 (en) 2011-08-31
CA2768838A1 (en) 2011-02-03
SG178115A1 (en) 2012-03-29
GEAP202012594A (en) 2020-01-27
AU2010276490A1 (en) 2012-03-08
EP2459525B1 (en) 2017-03-01
US8680294B2 (en) 2014-03-25
US20120178942A1 (en) 2012-07-12
EA022038B1 (en) 2015-10-30
CN102639492A (en) 2012-08-15
AU2010276490B2 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
IN2012DN02751A (en)
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
MX341133B (en) Compounds and methods.
TN2011000673A1 (en) Bace inhibitors
WO2011138281A3 (en) Process for the preparation of dithiine tetracarboxydiimides
MX2012008141A (en) Compounds and methods.
UA104438C2 (en) Method for the preparation of dabigatran and its intermediates
MX2011011776A (en) Triptolide prodrugs.
MX2009008660A (en) Method for the preparation of therapeutically valuable triphenylbutene derivatives.
MX344246B (en) Method for producing 5-fluorine-1-alkyl-3-fluoralkyl-1h-pyrazol-4 carbolic acid chlorides.
GEP20125512B (en) Process for synthesis of agomelatin
TN2013000354A1 (en) Synthesis of 2-carboxamide cycloamino urea derivatives
MX2012001411A (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid.
IN2012DN05081A (en)
MX2009010903A (en) Methods of preparing imidazole-based compounds.
UA106988C2 (en) A method of obtaining of 1-benzyl-3-hydroxymethyl-1h-indazole and its derivatives and required intermediate magnesium compounds
MX2012002818A (en) Novel method for synthesizing ivabradine and the addition salts thereof with a pharmaceutically acceptable acid.
IN2012DN01929A (en)
GEP20156234B (en) Agomelatine intermediates and preparation method thereof
MX2010009926A (en) New process for the preparatiion of cyclohexanecarboxylic acid dericatives.
MX2012010443A (en) Process for the preparation of 5-substituted 1-alkyltetrazoles.
IN2012DN02000A (en)
MX2013004193A (en) Process for the preparation of 3-(6-amino-pyridin-3yl)-2-acrylic acid derivatives.
MX2010003056A (en) Valomaciclovir polymorphs.
MX2013002656A (en) New process.